Document Type: Notice of Intent
Solicitation Number: NOI-RML-E-1808230
Posted Date: 08/23/2016
Response Date: 08/31/2016
Set Aside: none
NAICS Code: 325414
Contracting Office Address:
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB
Title: Bio-Plex Pro Human Cytokine 27-plex Assay and Pro Hu INF Panel 1 37-Plex kits
Primary Point of Contact: Secondary Point of Contact
Jesse Weidow Suzanne Miller
Description:
This notice is a Notice of Intent. (NOI). This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a Sole Source Firm-Fixed Price Contract under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements, and is not a request for competitive quotes.
The National Institute of Allergy and Infectious Diseases (NIAID) intends to award a firm-fixed price sole source contract to Bio-Rad Laboratories, Life Sciences Group, 2000 Alfred Nobel Drive, Hercules, CA 94547 for:
6 each CAT# M500KCAF0Y - Bio-Plex Pro Human Cytokine 27-plex Assay
6 each CAT# 171AL001M - Pro Hu INF Panel 1 37-Plex
Only Bio-Rad brand equipment and reagents will be considered.
The associated North American Industry Classification System (NAICS) code for this procurement is 325414 with a small business size standard of 1250. Bio-Rad is other than a small business.
This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within 30 days of this notice.
While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Bio-Rad is the only vendor which can provide the requested products for NIAID. However, firms that believe they can provide the capability required to fully meet the Government's requirement may submit a capability statement, proposal or quotation that will be considered by this Agency in writing to the identified point of contact within ten (10) days after publication of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement or submit offers on NOI-RML-E-1808230.
For additional information or to submit responses, please contact Jesse Weidow, [email protected].